Browsing 4 Medizinische Fakultät by Author "Gallwitz, Baptist"

Now showing items 1-20 of 72

Next Page >>

2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial

Gallwitz, Baptist; Rosenstock, Julio; Rauch, Thomas; Bhattacharya, Sudipta; Patel, Sanjay; von Eynatten, Maximilian; Dugi, Klaus A.; Woerle, Hans-Juergen (2012)
A Decision Support Tool for Appropriate Glucose-Lowering Therapy in Patients with Type 2 Diabetes

Javier Ampudia-Blasco, F.; Benhamou, Pierre Yves; Charpentier, Guillaume; Consoli, Agostino; Diamant, Michaela; Gallwitz, Baptist; Khunti, Kamlesh; Mathieu, Chantal; Ridderstrale, Martin; Seufert, Jochen; Tack, Cees; Vilsboll, Tina; Tra-Mi Phan; Stoevelaar, Herman (2015)
A safety evaluation of empagliflozin plus linagliptin for treating type 2 diabetes

Gallwitz, Baptist (2017)
Ambulante Diabetesversorgung in Deutschland – Ergebnisse einer Strukturerhebung in diabetologischen Praxen und Einrichtungen

Reichert, Dorothea; Scheper, Nikolaus; Mueller-Wieland, Dirk; Haeckl, Dennis; Bayer, Andreas; Horst, Michael; Gallwitz, Baptist (2018)
Behandlung des Diabetes mellitus Typ 2

Matthaei, S.; Bierwirth, R.; Fritsche, A.; Gallwitz, B.; Haering, H. -U.; Joost, H. -G.; Kellerer, M.; Kloos, C.; Kunt, T.; Nauck, M.; Schernthaner, G.; Siegel, E.; Thienel, F. (2012)
C-11-methionine PET/CT after inconclusive Tc-99m-MIBI-SPECT/CT for localisation of parathyroid adenomas in primary hyperparathyroidism

Braeuning, U.; Pfannenberg, C.; Gallwitz, B.; Teichmann, R.; Mueller, M.; Dittmann, H.; Reimold, M.; Bares, R. (2015)
Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide

Gallwitz, Baptist; Giorgino, Francesco (2021)
Clinical perspectives on the use of the GIP/GLP-1 receptor agonist tirzepatide for the treatment of type-2 diabetes and obesity

Gallwitz, Baptist (2022)
Clinical Use of DPP-4 Inhibitors

Gallwitz, Baptist (2019)
Contribution of insulin deficiency and insulin resistance to the development of type 2 diabetes: nature of early stage diabetes

Gallwitz, Baptist; Kazda, Christof; Kraus, Petra; Nicolay, Claudia; Schernthaner, Guntram (2013)
Diabetes mellitus an der Schnittstelle von Pädiatrie und Erwachsenenmedizin

Gallwitz, B.; Neu, A. (2018)
Diabetestherapie bei herzkranken Patienten : Orale Antidiabetika und Glucagon-like Peptide 1 (GLP-1)-Rezeptoragonisten

Gallwitz, Baptist (2023)
Dissociation of GLP-1 and insulin association with food processing in the brain: GLP-1 sensitivity despite insulin resistance in obese humans

Heni, Martin; Kullmann, Stephanie; Gallwitz, Baptist; Haering, Hans-Ulrich; Preissl, Hubert; Fritsche, Andreas (2015)
DPP4 gene variation affects GLP-1 secretion, insulin secretion, and glucose tolerance in humans with high body adiposity

Boehm, Anja; Wagner, Robert; Machicao, Fausto; Holst, Jens Juul; Gallwitz, Baptist; Stefan, Norbert; Fritsche, Andreas; Haering, Hans-Ulrich; Staiger, Harald (2017)
Effect of once-weekly dulaglutide on glycated haemoglobin (HbA1c) and fasting blood glucose in patient subpopulations by gender, duration of diabetes and baseline HbA1c

Gallwitz, Baptist; Dagogo-Jack, Samuel; Thieu, Vivian; Garcia-Perez, Luis-Emilio; Pavo, Imre; Yu, Maria; Robertson, Kenneth E.; Zhang, Nan; Giorgino, Francesco (2018)
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 1 diabetes: A randomized, open-label clinical trial

Home, Philip D.; Lam, Raymond L. H.; Carofano, Wendy L.; Golm, Gregory T.; Eldor, Roy; Crutchlow, Michael F.; Marcos, Michael C.; Rosenstock, Julio; Hollander, Priscilla A.; Gallwitz, Baptist (2018)
Efficacy and safety of MK-1293 insulin glargine compared with originator insulin glargine (Lantus) in type 2 diabetes: A randomized, open-label clinical trial

Hollander, Priscilla A.; Carofano, Wendy L.; Lam, Raymond L. H.; Golm, Gregory T.; Eldor, Roy; Crutchlow, Michael F.; Marcos, Michael C.; Rendell, Marc S.; Home, Philip D.; Gallwitz, Baptist; Rosenstock, Julio (2018)
Empagliflozin – Insulinunabhängige Kontrolle der Glykämieparameter bei Diabetes mellitus Typ 2 durch Inhibition des Natrium-Glukose-Cotransporters SGLT2

Gallwitz, B.; Merker, L.; Hohberg, C.; Schmid, V.; Moennig, E.; Brendel, M. D. (2015)
Exenatide twice daily versus glimepiride for prevention of glycaemic deterioration in patients with type 2 diabetes with metformin failure (EUREXA): an open-label, randomised controlled trial

Gallwitz, Baptist; Guzman, Juan; Dotta, Francesco; Guerci, Bruno; Simo, Rafael; Basson, Bruce R.; Festa, Andreas; Kiljanski, Jacek; Sapin, Helene; Trautmann, Michael; Schernthaner, Guntram (2012)
Extra-pancreatic effects of incretin-based therapies

Gallwitz, Baptist (2014)

Now showing items 1-20 of 72

Next Page >>

Report a Publication

Help

Browse

All of DSpace
This Collection

Browsing 4 Medizinische Fakultät by Author "Gallwitz, Baptist"

DSpace Repository

Browsing 4 Medizinische Fakultät by Author "Gallwitz, Baptist"

Browse

All of DSpace

This Collection

My Account